Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) Drug alert number: EL (23)A/19 Date issued: 23 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Metronidazole 200 mg/5 ml Oral Suspension, PL 30684/0236 Batch No
Read moreClass 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date
Read moreCommunity pharmacy contractors are not required to undertake a contractor-chosen or an NHS England determined clinical audit in 2023/24. This follows PSNC’s request to remove this clinical governance requirement for contractors in 2023/24. A clinical audit on anticoagulants is included in the Pharmacy Quality Scheme (PQS) 2023/24. If contractors choose to not participate in PQS,
Read moreFrom May 30th we will be known as Community Pharmacy England, with new branding designed to be more impactful and authoritative, helping us to better represent community pharmacy. Alongside the name change we will be starting to implement a new engagement and communications strategy to open up a better dialogue with pharmacy owners (our members). This is
Read morePSNC and others have issued a statement on the wellbeing of the pharmacy workforce, recognising their shared endeavour to support pharmacy teams across all sectors to deliver patient care. The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable to discuss the impact of pharmacy workforce wellbeing on patient safety. PSNC Director of Contractor
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Micronised Progesterone (Utrogestan®) 100mg capsules. MSN/2023/052 Tier 2 – medium impact Date of issue 19th May 2023 There are intermittent supplies of micronised progesterone (Utrogestan®) 100mg capsules until late 2023, resulting in brief periods every month when this product will be
Read moreIn response to a significant ongoing disruption to the supply of Utrogestan 100mg capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 19 May 2023, SSP056 enables community pharmacists in the UK to supply patients with no more than two months’ worth of supply of Utrogestan
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon 1mg powder for injection kit (GlucaGen®) . MSN/2023/051 Tier 2 – medium impact Date of issue 18th May 2023 There are two glucagon preparations available – GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens).
Read moreThe Department of Health and Social Care (DHSC) has today (18/05/2023) granted the following initial list of price concessions for May 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £19.60 Amisulpride 50mg tablets 60 £12.34 Benzoyl peroxide 5% / Clindamycin 1% gel 30 £11.45 Benzoyl peroxide 5% / Clindamycin 1% gel 60 £22.90 Bicalutamide
Read moreNHS England (NHSE) has announced from 1st June 2023, in a change from the previous Community Pharmacist Consultation Service (CPCS) service specification, claims for payment should be submitted within one month of, and no later than three months from the claim period for the chargeable activity provided. The change normalises the grace period for service
Read more
